Efficacy and safety of aceclofenac and drotaverine fixed-dose combination in the treatment of primary dysmenorrhoea: a double-blind, double-dummy, randomized comparative study with aceclofenac
Authors:
- 1 September 2010
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 152 (1) , 86-90
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoeaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2006
- The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stonesBJU International, 2003
- Patient and Physician Satisfaction with Aceclofenac: Results of the European Observational Cohort Study (Experience with Aceclofenac for Inflammatory Pain in Daily Practice)Current Medical Research and Opinion, 2002
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain, 2001
- Pharmacokinetics and bioavailability of drotaverine in humansEuropean Journal of Drug Metabolism and Pharmacokinetics, 1996
- Treatment of Primary Dysmenorrhea with Prostaglandin Synthetase Inhibitors—a Promising Therapeutic AlternativeActa Obstetricia et Gynecologica Scandinavica, 1978